FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2236153020> ?p ?o ?g. }

• W2236153020 endingPage "828" @default.
• W2236153020 startingPage "814" @default.
• W2236153020 abstract "A potential strategy to alleviate the aggregation of intrinsically disordered proteins (IDPs) is to maintain the native functional state of the protein by small molecule binding. However, the targeting of the native state of IDPs by small molecules has been challenging due to their heterogeneous conformational ensembles. To tackle this challenge, we applied a high-throughput chemical microarray surface plasmon resonance imaging screen to detect the binding between small molecules and monomeric full-length Tau, a protein linked with the onset of a range of Tauopathies. The screen identified a novel set of drug-like fragment and lead-like compounds that bound to Tau. We verified that the majority of these hit compounds reduced the aggregation of different Tau constructs in vitro and in N2a cells. These results demonstrate that Tau is a viable receptor of drug-like small molecules. The drug discovery approach that we present can be applied to other IDPs linked to other misfolding diseases such as Alzheimer’s and Parkinson’s diseases. Keywords: Alzheimer’s disease, drug discovery, high throughput screening, inhibitor, protein aggregation, tau, taupathies, therapeutic." @default.
• W2236153020 created "2016-06-24" @default.
• W2236153020 creator A5003261774 @default.
• W2236153020 creator A5010218046 @default.
• W2236153020 creator A5021368435 @default.
• W2236153020 creator A5030050112 @default.
• W2236153020 creator A5038452125 @default.
• W2236153020 creator A5048338049 @default.
• W2236153020 creator A5054307455 @default.
• W2236153020 creator A5055828464 @default.
• W2236153020 creator A5068941908 @default.
• W2236153020 creator A5082848087 @default.
• W2236153020 creator A5091898546 @default.
• W2236153020 date "2015-10-19" @default.
• W2236153020 modified "2023-10-18" @default.
• W2236153020 title "Identification of Small Molecule Inhibitors of Tau Aggregation by Targeting Monomeric Tau As a Potential Therapeutic Approach for Tauopathies" @default.
• W2236153020 cites W1601066682 @default.
• W2236153020 cites W1970686195 @default.
• W2236153020 cites W1979330374 @default.
• W2236153020 cites W1985002125 @default.
• W2236153020 cites W1986792544 @default.
• W2236153020 cites W1996199105 @default.
• W2236153020 cites W1996917933 @default.
• W2236153020 cites W2001752726 @default.
• W2236153020 cites W2004884414 @default.
• W2236153020 cites W2006051211 @default.
• W2236153020 cites W2009558341 @default.
• W2236153020 cites W2020970511 @default.
• W2236153020 cites W2021370614 @default.
• W2236153020 cites W2021914048 @default.
• W2236153020 cites W2026892692 @default.
• W2236153020 cites W2036294565 @default.
• W2236153020 cites W2038120434 @default.
• W2236153020 cites W2039069312 @default.
• W2236153020 cites W2041655987 @default.
• W2236153020 cites W2046436217 @default.
• W2236153020 cites W2049299089 @default.
• W2236153020 cites W2049391304 @default.
• W2236153020 cites W2055012646 @default.
• W2236153020 cites W2077859905 @default.
• W2236153020 cites W2084652316 @default.
• W2236153020 cites W2089475153 @default.
• W2236153020 cites W2092157608 @default.
• W2236153020 cites W2095151099 @default.
• W2236153020 cites W2099991048 @default.
• W2236153020 cites W2100835471 @default.
• W2236153020 cites W2102696255 @default.
• W2236153020 cites W2104034347 @default.
• W2236153020 cites W2110544463 @default.
• W2236153020 cites W2115015599 @default.
• W2236153020 cites W2136124977 @default.
• W2236153020 cites W2140631432 @default.
• W2236153020 cites W2158067137 @default.
• W2236153020 cites W2158907165 @default.
• W2236153020 cites W2159333258 @default.
• W2236153020 cites W2159377066 @default.
• W2236153020 cites W2159577356 @default.
• W2236153020 cites W2159701165 @default.
• W2236153020 cites W2165525275 @default.
• W2236153020 cites W2167104284 @default.
• W2236153020 cites W2333298841 @default.
• W2236153020 cites W2336922205 @default.
• W2236153020 cites W2396332735 @default.
• W2236153020 doi "https://doi.org/10.2174/156720501209151019104951" @default.
• W2236153020 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4997948" @default.
• W2236153020 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26510979" @default.
• W2236153020 hasPublicationYear "2015" @default.
• W2236153020 type Work @default.
• W2236153020 sameAs 2236153020 @default.
• W2236153020 citedByCount "52" @default.
• W2236153020 countsByYear W22361530202016 @default.
• W2236153020 countsByYear W22361530202017 @default.
• W2236153020 countsByYear W22361530202018 @default.
• W2236153020 countsByYear W22361530202019 @default.
• W2236153020 countsByYear W22361530202020 @default.
• W2236153020 countsByYear W22361530202021 @default.
• W2236153020 countsByYear W22361530202022 @default.
• W2236153020 countsByYear W22361530202023 @default.
• W2236153020 crossrefType "journal-article" @default.
• W2236153020 hasAuthorship W2236153020A5003261774 @default.
• W2236153020 hasAuthorship W2236153020A5010218046 @default.
• W2236153020 hasAuthorship W2236153020A5021368435 @default.
• W2236153020 hasAuthorship W2236153020A5030050112 @default.
• W2236153020 hasAuthorship W2236153020A5038452125 @default.
• W2236153020 hasAuthorship W2236153020A5048338049 @default.
• W2236153020 hasAuthorship W2236153020A5054307455 @default.
• W2236153020 hasAuthorship W2236153020A5055828464 @default.
• W2236153020 hasAuthorship W2236153020A5068941908 @default.
• W2236153020 hasAuthorship W2236153020A5082848087 @default.
• W2236153020 hasAuthorship W2236153020A5091898546 @default.
• W2236153020 hasBestOaLocation W22361530202 @default.
• W2236153020 hasConcept C11804247 @default.
• W2236153020 hasConcept C12554922 @default.
• W2236153020 hasConcept C136238340 @default.
• W2236153020 hasConcept C142724271 @default.
• W2236153020 hasConcept C161624437 @default.
• W2236153020 hasConcept C185592680 @default.
• W2236153020 hasConcept C2778670691 @default.

• next